Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 26

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 26
---
 the exercise of Common Warrants issued in the offerings of our Series A Preferred Stock, Series 
 B Preferred Stock and Series C Preferred Stock;                                                                                      |

| ● | 626,953                                                                                                                           
 shares of Common Stock issuable upon conversion of the Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred 
 Stock;                                                                                                                            |

| ● | 2,551,020 shares of Common Stock issuable upon the exercise of Offered Common 
 Warrants issued in this offering described in this prospectus; and            |

| ● | 2,251,020                                                                                                          
 shares of Common Stock issuable upon the exercise of Pre-Funded Warrants issued in this offering described in this 
 prospectus.                                                                                                        |

<div align='center'>8

RISK FACTORS</div>

Investing in our securities involves a high degree of risk. Before you decide to invest in our securities, you should consider carefully the risks described below, together with the other information contained in this prospectus, including our financial statements and the related notes appearing at the end of this prospectus. We believe the risks described below are the risks that are material to us as of the date of this prospectus. If any of the following risks actually occur, our business, results of operations and financial condition would likely be materially and adversely affected. In these circumstances, the market price of our securities could decline, and you may lose part or all of your investment.

Risks Related to this Offering

There is no public market for Offered Common Warrants or the Pre-Funded Warrants to purchase shares of our Common Stock being offered by us in this offering.

There
is no established public trading market for the Offered Common Warrants or the Pre-Funded
Warrants to purchase shares of our Common Stock that are being offered as part of this offering,
and we do not expect a market to develop. In addition, we do not intend to apply to list
the Offered Common Warrants or the Pre-Funded Warrants on any national securities exchange
or other nationally recognized trading system, including the Nasdaq Global Market. Without
an active market, the liquidity of the Offered Common Warrants and the Pre-Funded Warrants
will be limited.

The Offered Common Warrants and the Pre-Funded Warrants are speculative in nature.

The Offered Common Warrants
and the Pre-Funded Warrants do not confer any rights of Common Stock ownership on their holders, such as voting rights or the right to
receive